Technology
Health
Pharmaceutical

Hutchison China Meditech

$29.00
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.22 (0.76%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell HCM and other stocks, options, ETFs, and crypto commission-free!

About

Hutchison China MediTech Limited American Depositary Shares, also called Hutchison China Meditech, is a holding company, which engages in the research and development, manufactures, and sells pharmaceuticals and health oriented consumer products. It operates through the Innovation Platform and Commercial Platform segments. Read More The Innovation Platform segment relates to research and development of innovative therapeutics in oncology and autoimmune diseases. The Commercial Platform segment relates to prescription drugs which develops, manufacture, markets, and sale of prescription pharmaceuticals; and consumer health which comprised of development, manufacture, distribution, and marketing of over-the-counter pharmaceuticals, and consumer health products. The company was founded in June 2000 and is headquartered in Hong Kong.

Employees
714
Headquarters
Hong Kong, Central & Western
Founded
2000
Market Cap
3.87B
Price-Earnings Ratio
Dividend Yield
Average Volume
218.32K
High Today
$29.27
Low Today
$28.43
Open Price
$28.92
Volume
43.64K
52 Week High
$39.68
52 Week Low
$20.83

Collections

Technology
Health
Pharmaceutical
Research And Development
Consumer Products
Therapy
Advertising and Marketing
Retail

News

Seeking AlphaMar 11

Hutchison China MediTech Ltd (HCM) CEO Christian Hogg on Q4 2018 Results - Earnings Call Transcript

Hutchison China MediTech Ltd (NASDAQ:HCM) Q4 2018 Earnings Conference Call March 11, 2019 4:00 AM ET Company Participants Christian Hogg - CEO & Executive Director Conference Call Participants Michael Mitchell - Panmure Gordon Cinney Zhang - Bloomberg Intelligence Susie Jana - Edison Investment Research Limited Christian Hogg Okay. All right. Well, 9:00. So thank you, everybody, for attending today the Hutchison China MediTech 2018 Results Presentation. As always, it's a very detailed presentation, ...

77
MarketBeatMar 7

Stock Price, News, & Analysis for HUTCHISON CHINA/S

Hutchison China MediTech Limited, a biopharmaceutical company, engages in the research, development, manufacture, and sale of pharmaceuticals and healthcare products primarily in the People's Republic of China and Hong Kong.

1

Earnings

Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Estimated
Actual
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.